Vanda Pharmaceuticals | Credores Comerciais





Credores Comerciais Alterar Data
Acadia Pharmaceuticals USD 21.75M 1.65M 2025-09
Agios Pharmaceuticals USD 19.55M 2.02M 2025-09
Akebia Therapeutics USD 10.09M 1.47M 2025-09
Alnylam Pharmaceuticals USD 117.59M 15.2M 2025-09
Anika Therapeutics USD 4.73M 39K 2025-09
Arrowhead Research USD 32.94M 15.26M 2025-12
AstraZeneca USD 25.03B 1.04B 2025-09
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Eli Lilly USD 4.26B 186.5M 2025-09
Enanta Pharmaceuticals USD 1.95M 1.6M 2025-09
Esperion Therapeutics USD 77.51M 2.81M 2025-09
Halozyme Therapeutics USD 15.36M 3.33M 2025-09
Heron Therapeutics USD 12.02M 20K 2025-09
Insmed USD 79.59M 1.24M 2025-09
J&J USD 9.62B 161M 2025-09
Lexicon Pharmaceuticals USD 5.9M 4.79M 2025-06
Ligand Pharmaceuticals USD 27.76M 1.72M 2025-09
Merck USD 4.15B 102M 2025-09
Minerva Neurosciences USD 945K 48K 2025-09
Moderna USD 267M 92M 2025-09
Novartis USD 4.56B 49M 2025-09
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 36.62M 169.69M 2025-09
Puma Biotechnology USD 6.39M 962K 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.93B 927M 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Veracyte USD 5.51M 5.94M 2025-09


Vanda Pharmaceuticals Credores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.